Evidence map›Paper›PMID 40320755›Full record

SynthesisJournal of Parkinson's disease2025

Early thinking palliative care for people with Parkinson's disease: A thematic synthesis based on a systematic mixed-methods review.

Michela Garon, Christiane Weck, Valentina Leta, Bauke W Dijkstra, Catharina Muente, Giovanni Gentile, Dhaval Trivedi, Marieke M Groot, Stefan Lorenzl, Per Odin and 12 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Improving Advance Care Planning for People with Parkinson's.Movement disorders clinical practice · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Michela GaronParkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padua, Italy.ORCID 0000-0003-4945-5498
Christiane WeckInstitute of Palliative Care, Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0003-4980-0300
Valentina LetaDepartment of Basic & Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0002-5794-7540
Bauke W DijkstraRadboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.ORCID 0000-0002-6921-482X
Catharina MuenteRadboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.ORCID 0000-0002-3640-4010
Giovanni GentileParkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padua, Italy.ORCID 0000-0001-6393-2655
Dhaval TrivediDepartment of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology and Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Cutcombe Road, London, UK.
Marieke M GrootRotterdam University of Applied Sciences, Research Centre Innovations in Care, Rotterdam, The Netherlands.ORCID 0000-0002-5740-3607
Stefan LorenzlInstitute of Palliative Care, Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0002-1165-0821
Per OdinDivision of Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.ORCID 0000-0002-0756-7478
Spyridon KonitsiotisDepartment of Neurology, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece.ORCID 0000-0002-5217-1317
David J PedrosaDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0002-5403-1959
Dimitrios I FotiadisUnit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.ORCID 0000-0002-7362-5082
Marjan J MeindersRadboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.ORCID 0000-0001-6491-7035
Bastiaan R BloemRadboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.ORCID 0000-0002-6371-3337
Anette E SchragDepartment of Clinical Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
Laura GroverDepartment of Clinical Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0001-6857-2601
Pille TabaDepartment of Neurology and Neurosurgery, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia; Clinic of Neurology, Tartu University Hospita, Tartu, Estonia.ORCID 0000-0002-1315-1065
K Ray ChaudhuriDepartment of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology and Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Cutcombe Road, London, UK.ORCID 0000-0003-2815-0505
Angelo AntoniniParkinson and Movement Disorders Unit, Study Center for Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padua, Italy.ORCID 0000-0003-1040-2807
Piret PaalInstitute of Palliative Care, Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0002-1341-3248
PD_Pal consortium

Funding

Wellcome Trust
6 · The paper itself

Abstract

BackgroundParkinson's disease is a progressive neurodegenerative disorder. Awareness and the evidence supporting the merits of palliative care (PC) approaches to people with Parkinson's disease (PwP) are increasing.ObjectiveThis review aimed to address four key questions related to PC for PwPs and their caregivers: i) What are the indicators for timely access to PC? ii) When should PC be introduced? iii) What are the current care models for providing PC? iv) What are the barriers and facilitators at the organizational level?MethodsA systematic literature search was conducted in PubMed, CINAHL, Cochrane, EMBASE, and MEDLINE (2006-2024). Six reviewers independently screened abstracts and full texts, and thematic synthesis was applied to develop analytical themes. Reporting followed PRISMA guidelines.ResultsOut of 894 studies, 70 were included. PwPs were infrequently referred to PC services, and while several referral criteria were identified, no consensus emerged. Barriers to accessing PC included insufficient information, inadequate education, difficulties determining referral timing, limited home-based care options, inconsistent provider support, and disparities linked to socioeconomic and cultural factors. Facilitators included improved care coordination and education for PwPs, caregivers, and healthcare providers. Effective PC models were identified, including home-based, hospital-based, and community-based approaches, which improved quality of life and reduced healthcare costs.ConclusionsEstablishing consensus on referral timing and criteria is essential for integrating PC into Parkinson's disease care. Overcoming barriers requires enhanced education, better care coordination, and targeted interventions to address disparities, ensuring comprehensive, patient-centred care for PwPs and their caregivers.

Indexed as

Health Services AccessibilityPalliative CareParkinson DiseaseCaregiversHumanshealth services accessibilityneeds assessmentpalliative careParkinsonian disordersParkinson’s disease

Identifiers

PMID40320755
PMCPMC13347479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.